Koch Institute receives $1M from Takeda to support immuno-oncology research February 10, 2017 CenterWatch Staff
Epinomics, Parker Institute to collaborate for cancer immunotherapy at Stanford University February 10, 2017 CenterWatch Staff
Acorda announces positive phase III CVT-301 results for Parkinson’s February 9, 2017 CenterWatch Staff
Armetheon to conduct a 1000 patient single phase III study prior to NDA filing for Tecarfarin February 9, 2017 CenterWatch Staff
Aerie Pharmaceuticals appoints Huan Sheng director of Clinical Research and Drug Safety February 8, 2017 CenterWatch Staff